Related Experiment Video

Updated: May 12, 2026

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
08:53

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1

Published on: February 18, 2011

Cooperativity of Rb, Brca1, and p53 in malignant breast cancer evolution

Prashant Kumar1, Malini Mukherjee, Jacob P S Johnson

  • 1Department of Cancer Biology, University of Massachusetts Medical School, Worcester, Massachusetts, USA.

Plos Genetics
|November 23, 2012
PubMed

Insights

Combined Rb and p53 pathway inactivation prevents mammary cell death. This, with Brca1 defects, accelerates aggressive, metastatic triple-negative breast cancer in mice.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Triple-negative breast cancers (TNBC) often exhibit Basal-like molecular features.
  • Defects in Rb, p53, and Brca1 pathways are linked to TNBC and Basal-like subtypes.

Purpose of the Study:

  • To investigate the combined effects of Rb, p53, and Brca1 pathway inactivation on mammary tumor development.
  • To determine if these pathway defects are sufficient to drive aggressive, metastatic breast cancer phenotypes.

Main Methods:

  • Utilized mouse genetic models to inactivate Rb, p53, and Brca1 pathways in mammary epithelium.
  • Analyzed tumor latency, metastasis, histology, and gene expression profiles.
  • Assessed the impact on mammary involution and tumor progression.

Main Results:

  • Combined Rb and p53 inactivation suppressed mammary involution-associated cell death.
  • Concomitant inactivation of all three pathways (Rb, p53, Brca1) led to highly penetrant, metastatic adenocarcinomas with reduced tumor latency.
  • Tumors exhibited poor differentiation, metaplasia, necrosis, and molecular features of Basal-like and Claudin-low subtypes.

Conclusions:

  • Combined Rb and p53 pathway inactivation is sufficient to block physiological cell death during mammary involution.
  • The simultaneous disruption of Rb, p53, and Brca1 pathways drives the development of aggressive, metastatic triple-negative breast cancers in mice.
  • These findings highlight the critical roles of these tumor suppressor pathways in preventing aggressive breast cancer subtypes.

More Related Videos

Visualization of DNA Repair Proteins Interaction by Immunofluorescence07:55

Visualization of DNA Repair Proteins Interaction by Immunofluorescence

Published on: June 26, 2020

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...